Market News (Page 106) - TendieTensor

Market News Page 106 of 159 • 3,956 articles

MYR Group Inc. to Attend UBS Global Industrials and Transportation Conference in December

GlobeNewswire Inc. • Jennifer Harper

MYR Group Inc. to Attend UBS Global Industrials and Transportation Conference in December

11/03/2025 04:00 PM • MYR Group Inc., a specialty electrical contractor, will attend the UBS Global Industrials and Transportation investor conference on December 3, 2025, in Manalapan, Florida. CEO Rick Swartz and CFO Kelly Huntington will meet with institutional investors.

VNO - Mentioned briefly in a conference call title with no substantive details provided
MYRG - The article is a standard conference announcement with no explicit positive or negative indicators, presenting routine business communication about an upcoming investor meeting

#investor conference #electrical contractors #infrastructure #utilities

Sonoco Completes Sale of ThermoSafe Unit to Arsenal Capital Partners

GlobeNewswire Inc. • Roger Schrum

Sonoco Completes Sale of ThermoSafe Unit to Arsenal Capital Partners

11/03/2025 04:00 PM • Sonoco Products Company has sold its ThermoSafe business unit to Arsenal Capital Partners for up to $725 million, concluding its portfolio transformation strategy and focusing on metal and paper packaging segments.

SON - The sale represents a strategic portfolio simplification, reducing debt and focusing on core business segments

#divestiture #packaging #acquisition #portfolio transformation

Arvinas to Present Preclinical Data for ARV-393 at the 2025 American Society of Hematology (ASH) Annual Meeting

GlobeNewswire Inc. • Arvinas, Inc.

Arvinas to Present Preclinical Data for ARV-393 at the 2025 American Society of Hematology (ASH) Annual Meeting

11/03/2025 04:00 PM • Arvinas will present preclinical data for ARV-393, a PROTAC BCL6 degrader targeting non-Hodgkin lymphoma, at the 2025 ASH Annual Meeting in Orlando, Florida.

ARVN - Company is presenting novel preclinical research, advancing its protein degradation platform with potential therapeutic implications for lymphoma treatment

#PROTAC #BCL6 #protein degradation #non-Hodgkin lymphoma #clinical research

OXFORD BANK CORPORATION ANNOUNCES THIRD QUARTER 2025 AND NINE-MONTH OPERATING RESULTS

Benzinga • Prnewswire

OXFORD BANK CORPORATION ANNOUNCES THIRD QUARTER 2025 AND NINE-MONTH OPERATING RESULTS

11/03/2025 03:15 PM • Oxford Bank Corporation reported Q3 2025 earnings of $3.06 million, showing growth in net interest income and strong deposit relationships. The bank continues to focus on technology, relationship banking, and small business lending initiatives.

VNOpM - Mentioned briefly in a conference call title with no substantive details provided
OXBC - The company reported increased earnings, growth in net interest income, significant deposit increases, and strategic initiatives in small business lending. The CEO expressed cautious optimism about future performance and the bank's ability to deliver consistent value to stakeholders.

#banking #earnings #net interest income #deposits #small business lending

The Motley Fool • Chris Macdonald

2 Reasons Why Ethereum Slumped 6% Today

11/03/2025 03:08 PM • Ethereum experienced a 6% decline due to a $128 million crypto hack on Balancer and negative sentiment from crypto influencers, despite a recent large token purchase by BitMine.

VNOpN - Mentioned briefly in a conference call title with no substantive details provided
BMNR - Purchased 82,000 ETH tokens, which could be seen as a bullish signal despite the current market downturn

#cryptocurrency #blockchain #Ethereum #crypto hack #market sentiment

Intel’s 103% Rally Marks Deep Structural Comeback Backed by CHIPS Act Capital

Investing.com • Itai Smidt

Intel’s 103% Rally Marks Deep Structural Comeback Backed by CHIPS Act Capital

11/03/2025 03:03 PM • Intel has experienced a remarkable turnaround in 2025, with a 103% stock price increase driven by strategic restructuring, government support via the CHIPS Act, and a renewed focus on AI and foundry services.

VNOpO - Mentioned briefly in a conference call title with no substantive details provided
INTC - Significant stock price growth, government investment, strategic partnerships, improved financial metrics, and positive analyst outlook

#semiconductor #AI #CHIPS Act #foundry #technology transformation

Why Cipher Mining Stock Soared on Monday Morning

The Motley Fool • Anders Bylund

Why Cipher Mining Stock Soared on Monday Morning

11/03/2025 03:01 PM • Cipher Mining's stock jumped over 34% after signing a 15-year, $5.5 billion data center agreement with Amazon Web Services for AI workloads, transforming the company from a Bitcoin miner to an AI data center provider.

CIFR - Stock rose 34% due to strategic pivot to AI data center services with a long-term AWS contract, despite missing quarterly earnings estimates

#Bitcoin mining #AI data centers #Amazon Web Services #cryptocurrency

Apple Stock Is Trending Down: What's Going On?

Benzinga • Evette Mitkov

Apple Stock Is Trending Down: What's Going On?

11/03/2025 02:52 PM • Apple's stock is experiencing a downward trend due to potential challenges in 2026, including regulatory pressures, AI integration concerns, and manufacturing risks in China.

ATYR - Briefly mentioned with no specific negative details
AAPL - Despite current stock pullback, the company remains resilient with a 9.6% year-to-date performance and potential AI improvements with Google partnership

#Apple #AI #Siri #Google #stock market #technology

Deadline Alert: Jasper Therapeutics, Inc. (JSPR) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit

GlobeNewswire Inc. • Glancy Prongay & Murray Llp

Deadline Alert: Jasper Therapeutics, Inc. (JSPR) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit

11/03/2025 02:50 PM • Jasper Therapeutics faces a class action lawsuit alleging securities fraud after revealing issues with a drug product lot that impacted clinical trial results, leading to study halts and significant stock price decline.

OGN - Stock price plummeted 23% after announcement of improper sales practices and abrupt CEO departure
JSPR - Company disclosed manufacturing issues in clinical trials, halted multiple studies, implemented cost-cutting measures, and experienced a 55.1% stock price drop, indicating significant operational and financial challenges

#securities fraud #clinical trials #briquilimab #class action lawsuit

Deadline Alert: RCI Hospitality Holdings, Inc. (RICK) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit

GlobeNewswire Inc. • Glancy Prongay & Murray Llp

Deadline Alert: RCI Hospitality Holdings, Inc. (RICK) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit

11/03/2025 02:48 PM • Law firm alerts investors about a class action lawsuit against RCI Hospitality Holdings for alleged tax fraud, bribery, and misleading statements, with a November 20, 2025 deadline to file a lead plaintiff motion.

RICK - Company and executives were indicted for criminal tax fraud and bribery, facing 79 charges, which caused a 15.9% stock price drop and potential legal and financial consequences

#securities fraud #class action #tax fraud #bribery #investor lawsuit

Deadline Alert: MoonLake Immunotherapeutics (MLTX) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit

GlobeNewswire Inc. • Glancy Prongay & Murray Llp

Deadline Alert: MoonLake Immunotherapeutics (MLTX) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit

11/03/2025 02:46 PM • MoonLake Immunotherapeutics faces a class action lawsuit after announcing disappointing Phase 3 results for its drug candidate sonelokimab, which failed to match competitor's drug efficacy, causing an 89.9% stock price drop.

MLTX - Stock price dropped 89.9% after revealing drug candidate's lack of competitive advantage, facing potential securities fraud allegations for allegedly misleading investors about drug's clinical potential

#securities fraud #class action lawsuit #drug development #clinical trials #nanobody

Tevogen Clarifies Reported Financials, Highlighting Strong Capital Efficiency and Low Cash Burn

GlobeNewswire Inc. • Kirti Desai (Cfo)

Tevogen Clarifies Reported Financials, Highlighting Strong Capital Efficiency and Low Cash Burn

11/03/2025 02:45 PM • Tevogen Bio explains its accumulated deficit of $129 million, highlighting that the majority represents non-cash expenses and is offset by additional paid-in capital, with total cash loss under $42 million.

NKE - Mentioned as experiencing similar industry challenges and ongoing turnaround efforts, with higher valuation compared to Lululemon
TVGN - The company provides transparent financial context, explaining complex accounting metrics while acknowledging potential challenges in raising additional capital and executing growth strategies

#financial reporting #biotechnology #GAAP #deficit #capital raise

TEN Ltd. Announces Date for the Third Quarter and Nine Months 2025 Results, Conference Call and Webcast

GlobeNewswire Inc. • Tsakos Energy Navigation Ltd.

TEN Ltd. Announces Date for the Third Quarter and Nine Months 2025 Results, Conference Call and Webcast

11/03/2025 02:45 PM • TEN Ltd. will report its Q3 and nine-month 2025 financial results on November 20, 2025, with a conference call and webcast to discuss the company's performance and outlook.

TEN - The article is a standard financial results announcement without indicating significant positive or negative performance indicators

#financial results #conference call #webcast #earnings #maritime

Deadline Alert: Baxter International, Inc. (BAX) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit

GlobeNewswire Inc. • Glancy Prongay & Murray Llp

Deadline Alert: Baxter International, Inc. (BAX) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit

11/03/2025 02:42 PM • Baxter International faces a class action lawsuit alleging securities fraud related to safety issues with its Novum IQ Large Volume Pump, which reportedly caused patient injuries and deaths, leading to a significant stock price drop.

BAX - The company is accused of concealing serious safety defects in its medical device, resulting in patient injuries and deaths, multiple warning letters, an FDA Class I recall, and a 22.4% stock price decline

#securities fraud #medical device #patient safety #stock decline #class action lawsuit

The Heart-Body Connection: How Other Organ Systems Affect Heart Health

GlobeNewswire Inc. • Michael French

The Heart-Body Connection: How Other Organ Systems Affect Heart Health

11/03/2025 02:35 PM • A new American Heart Association initiative highlights the interconnected health of heart, kidney, and metabolic systems, revealing that 9 in 10 U.S. adults have at least one component of CKM syndrome, which increases risks of heart attack, stroke, and heart failure.

NVO - Mentioned as a founding sponsor of the CKM Health Initiative without specific positive or negative context

#heart health #CKM syndrome #cardiovascular health #metabolic health #kidney function

ConnectM Acquires Amperics, Expanding Keen Labs' Portfolio and Advancing the Future of Virtual Power Plants & Energy-Intelligent AI Data Centers

Benzinga • Globe Newswire

ConnectM Acquires Amperics, Expanding Keen Labs' Portfolio and Advancing the Future of Virtual Power Plants & Energy-Intelligent AI Data Centers

11/03/2025 02:30 PM • ConnectM Technology Solutions has acquired Amperics, a developer of hybrid battery-supercapacitor technology, to enhance its virtual power plant and energy-intelligent AI data center capabilities. The acquisition will integrate Amperics' technology into Keen Labs and expand ConnectM's distributed energy resources strategy.

CIFR - Valued as if full approved power portfolio is converted, estimated ~$125 million annualized cash operating profits
CNTM - Company is expanding its technological capabilities, acquiring innovative technology, and strategically positioning itself in emerging energy markets

#acquisition #virtual power plants #energy technology #AI data centers #battery technology

Telecom Giants Split Paths as Q3 Results Reveal a Growing Divide

Investing.com • Leo Miller

Telecom Giants Split Paths as Q3 Results Reveal a Growing Divide

11/03/2025 02:20 PM • The Big Three US telecom stocks showed divergent Q3 performance, with AT&T and T-Mobile delivering strong subscriber growth while Verizon struggled with customer retention and strategic challenges.

CIFRW - Valued as if full approved power portfolio is converted, estimated ~$125 million annualized cash operating profits
T - Added 405,000 net postpaid mobile phone subscribers, grew fiber revenues by 17%, increased converged customer percentage, and maintained full-year EPS guidance

#telecom #Q3 earnings #mobile subscribers #fiber network #5G

Apollo Funds Commit $6.5 Billion to Ørsted’s Hornsea 3 in the UK

GlobeNewswire Inc. • Apollo

Apollo Funds Commit $6.5 Billion to Ørsted’s Hornsea 3 in the UK

11/03/2025 02:00 PM • Apollo-managed funds will invest $6.5 billion for a 50% stake in Ørsted's Hornsea 3, the world's largest offshore wind project in the North Sea, with a 2.9GW capacity to power over 3 million UK households.

MARA - Estimated ~$245 million annualized cash operating profits, indicating stable performance
APO - Expanding infrastructure portfolio with significant investment in renewable energy project

#offshore wind #renewable energy #infrastructure investment #joint venture #energy transition

What's Up With The Rise In Eli Lilly Stock Today?

Benzinga • Evette Mitkov

What's Up With The Rise In Eli Lilly Stock Today?

11/03/2025 01:54 PM • Eli Lilly announced a $3 billion investment in a new manufacturing plant in the Netherlands to produce oral medications, focusing on advanced manufacturing technologies and expanding its global supply chain.

IREN - Leads in HPC colocation at ~80% approved capacity, estimated ~$600 million annualized cash operating profits
LLY - Company is making significant strategic investment in European manufacturing, expanding production capabilities, and planning to submit new obesity treatment for regulatory approval

#pharmaceutical #manufacturing #expansion #oral medicine #Netherlands

Lactic Acid Market Size | Companies Analysis 2025- 2034

GlobeNewswire Inc. • Towards Chemical And Materials

Lactic Acid Market Size | Companies Analysis 2025- 2034

11/03/2025 01:49 PM • The global lactic acid market is expected to grow from $4.62 billion in 2025 to $9.82 billion by 2034, driven by increasing demand for biodegradable plastics, sustainable packaging, and eco-friendly materials across multiple industries.

CLSK - Estimated ~$415 million annualized cash operating profits, suggesting steady performance
BASFY - Mentioned as a key market player in lactic acid production with potential for growth in sustainable materials

#lactic acid #bioplastics #sustainability #fermentation #biodegradable polymers

Ford and GM Stocks Jump—Is the Auto Rebound Real?

Investing.com • Dan Schmidt

Ford and GM Stocks Jump—Is the Auto Rebound Real?

11/03/2025 01:47 PM • U.S. automakers Ford and GM reported strong Q3 2025 earnings despite industry challenges like high interest rates and tariffs, signaling potential recovery in the automotive sector with a shift towards hybrid models and traditional trucks/SUVs.

CLSKW - Estimated ~$415 million annualized cash operating profits, suggesting steady performance
F - Beat Q3 earnings expectations but lowered full-year guidance due to EV losses and aluminum plant fire costs, indicating mixed performance

#automotive #tariffs #interest rates #electric vehicles #earnings #Q3 2025

Alvotech Shares Plunge 33% After FDA Flags Issues

Benzinga • Vandana Singh

Alvotech Shares Plunge 33% After FDA Flags Issues

11/03/2025 01:17 PM • Biotech company Alvotech received a complete response letter from the FDA for its biosimilar drug AVT05, citing manufacturing facility deficiencies. The company's stock dropped significantly, and it revised its 2025 revenue and EBITDA projections downward.

ALVO - Stock plunged 33%, received FDA complete response letter, lowered financial projections, and must resolve manufacturing facility issues

#biosimilar #FDA #manufacturing #drug approval #facility inspection

Shell Plans $1 Billion Angola Oil Investment During Offshore Exploration Push: Report

Benzinga • Lekha Gupta

Shell Plans $1 Billion Angola Oil Investment During Offshore Exploration Push: Report

11/03/2025 01:05 PM • Shell plans to invest approximately $1 billion in new oil blocks in Angola, securing exclusive exploration rights for offshore blocks to boost production in the southern African nation.

UPS - Improved revenue guidance for holiday quarter, indicating potential positive market conditions
SHEL - The company is expanding its exploration portfolio, securing new offshore blocks and investing $1 billion in Angola, indicating strategic growth and commitment to production expansion

#Angola #oil investment #offshore exploration #energy #Shell

Nvidia, Amazon Extend Rally, Bitcoin Sinks To $107,000: What's Moving Markets Monday?

Benzinga • Piero Cingari

Nvidia, Amazon Extend Rally, Bitcoin Sinks To $107,000: What's Moving Markets Monday?

11/03/2025 01:01 PM • Wall Street opened mixed on Monday, with AI-driven mega-cap stocks rallying while broader markets remained cautious. Nvidia and Amazon saw significant gains, while cryptocurrencies experienced notable declines.

TSCO - Anticipated strength in organic sales and favorable Q4 guidance
NVDA - Stock jumped 3.3%, lifting market capitalization to $5.08 trillion and further cementing its market dominance

#AI #market rally #cryptocurrency #tech stocks #earnings

Chevron's Big Projects Start Paying Off And There's More Ahead, Analyst Says

Benzinga • Lekha Gupta

Chevron's Big Projects Start Paying Off And There's More Ahead, Analyst Says

11/03/2025 01:01 PM • Chevron reported strong Q3 results with higher upstream production and refining margins. Bank of America analyst reaffirmed a Buy rating with a $183 price target, highlighting strong project execution and growth potential.

PG - Mentioned in context of potential Q4 performance, no specific details provided
CVX - Exceeded earnings expectations, strong production growth (27% US, 21% global), successful project execution, and potential for further expansion with Hess integration and Tengiz contract extension

#oil #production #earnings #Permian #upstream #refining